​

Minerva Neurosciences (NERV) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

NERV Stock Forecast

Minerva Neurosciences (NERV) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $10.00, with a high of $10.00 and a low of $10.00. This represents a 142.72% increase from the last price of $4.12.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $10 Avg: $10 Low: $10 Last Closed Price: $4.12

NERV Stock Rating

Minerva Neurosciences stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

NERV Price Target Upside V Benchmarks

TypeNameUpside
StockMinerva Neurosciences142.72%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$10.00$7.50
Last Closing Price$4.12$4.12$4.12
Upside/Downside-142.72%82.04%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26111--3
Aug, 261-2--3
Jul, 261-2--3
Jun, 261-2--3
May, 261-2--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 14, 2026Andrew TsaiJefferies$10.00$3.92155.10%142.72%
Dec 01, 2025Jefferies$5.00$3.8031.58%21.36%
Aug 07, 2024Douglas TsaoH.C. Wainwright$5.00$2.9470.07%21.36%
May 02, 2024Douglas TsaoH.C. Wainwright$7.00$2.40191.67%69.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 14, 2026JefferiesMixedBuyupgrade
Aug 14, 2026JefferiesHoldMixedupgrade
Apr 15, 2026CitigroupOutperforminitialise
Mar 12, 2026H.C. WainwrightNeutralNeutralhold
Dec 01, 2025JefferiesHoldHoldhold
Aug 07, 2024H.C. WainwrightNeutralNeutralhold
May 02, 2024H.C. WainwrightNeutralNeutralhold

Financial Forecast

EPS Forecast

$-35 $-27 $-19 $-11 $-3 $5 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.35$-4.61$0.19$-34.67---
Avg Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
High Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
Low Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
Surprise %37.30%8.22%-163.33%1193.66%---

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
High Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
Low Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
Surprise %-------

Net Income Forecast

$-300M $-230M $-160M $-90M $-20M $50M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.91M$-30.01M$1.44M$-293.42M---
Avg Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
High Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
Low Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
Surprise %12.59%8.26%-173.72%1582.75%---

NERV Forecast FAQ

Is Minerva Neurosciences stock a buy?

Minerva Neurosciences stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Minerva Neurosciences is a favorable investment for most analysts.

What is Minerva Neurosciences's price target?

Minerva Neurosciences's price target, set by 7 Wall Street analysts, averages $10 over the next 12 months. The price target range spans from $10 at the low end to $10 at the high end, suggesting a potential 142.72% change from the previous closing price of $4.12.

How does Minerva Neurosciences stock forecast compare to its benchmarks?

Minerva Neurosciences's stock forecast shows a 142.72% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Minerva Neurosciences over the past three months?

  • September 2026: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Minerva Neurosciences’s EPS forecast?

Minerva Neurosciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.88, marking a -94.58% decrease from the reported $-34.67 in 2025. Estimates for the following years are $1.42 in 2027, and $1.62 in 2028.

What is Minerva Neurosciences’s revenue forecast?

Minerva Neurosciences's average annual revenue forecast for its fiscal year ending in December 2026 is $19.76M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $56.49M, and $137.88M for 2028.

What is Minerva Neurosciences’s net income forecast?

Minerva Neurosciences's net income forecast for the fiscal year ending in December 2026 stands at $-12.232M, representing a -95.83% decrease from the reported $-293M in 2025. Projections indicate $9.24M in 2027, and $10.54M in 2028.